Amprius awarded $75M defense grant for U.S. drone battery production
News of Amprius securing a $75 million defense grant for U.S. drone battery production
The current price of $9.75 is positioned above the $8.76 support level and below the $10.60 resistance level, leading to the assessment that this is a defensive buying zone. News regarding defense industry battery orders and the recent 7-day upward trend of +7.1% also serve as the rationale for the purchase.
If the stock price reaches the resistance level of $10.60, take profit, and if it falls to the support level of $8.76, cut losses. This criterion is based on the resistance and support levels presented by REPORTING.
RSI(14) 47.7 (neutral), moving averages not in bullish alignment (trend unclear), trading volume 0.91x the 20-day average (slight decrease in volume), 7-day volatility +7.1% (price increase)
Following similar positive news announcements between 2026-08-04 and 2026-09-28, AMPX showed gains ranging from +0.8% to +13.2%. While the recent Defense Department subsidy news raised expectations for a similar pattern, the magnitude of the increase may be limited. VEEE (+451.7%), LRCX (+346.8%), and AEMD (+336.4%) lack direct similarity and are provided for reference as top-performing stocks globally.
Although the forecast expected a 3.5% increase, the stock actually fell by 12.2%, hitting the stop-loss level. The purchase was made based on news and the recent upward trend. While a short-term defensive stance was justified as the current price was above the support line, the moving averages in non-alignment and slightly decreased trading volume indicated a weakening trend, and overlooking this was the cause of the loss.
For the next trade, technical signals (moving average alignment, increased volume) will be added to the buy conditions, and the stop-loss level will be set slightly above the current support line to limit risk. In addition, rather than overestimating expected returns based on news alone, past similar reaction patterns will be quantitatively reviewed.